Medtronic has launched its new StealthStation technology at the AANS annual conference in Los Angeles. StealthStation technology has been a mainstay in neurosurgery suites for the past 25 years, being used in more than 2.25 million procedures. With the new StealthStation S8 model, Medtronic brings an advanced solution to neurosurgeons with enhanced workflows, efficiencies, and more comprehensive data integration, providing useful surgical na...

Medtronic has announced FDA approval and U.S. launch of the CoreValve Evolut PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at high or extreme risk for open heart surgery. The approval comes on the heels of new 30-day clinical data that was unveiled at the ACC 66th Annual Scientific Session, which showed high survival, low rates of stroke, minimal paravalvular leak (PVL) and hemodynamics for the self-expand...

Medtronic has released an advanced surgical stapler, the Signia Stapling System, which sports sensors that detect the tissue being worked and adjust its speed to produce optimal staple lines. The company’s Adaptive Firing technology measures how much force it takes a staple to penetrate through tissue, controlling in real-time the speed of the stapler. The tissue sensing data and status of the stapler, including the battery charge, is ...

  Medtronic is releasing a few coronary devices, including the DxTerity diagnostic angiography catheters, DxTerity TRA diagnostic catheters, InTRAkit access kit, and the TRAcelet compression device. All the products already have received U.S. and European regulatory approvals.

Medtronic landed FDA clearance for its CardioInsight 3D cardiac mapping system that’s used to locate sources of arrhythmias. The system consists of an ECG vest with a whopping 252 electrodes. It’s used to collect highly detailed skin surface electric signal data while the patient is inside a CT scanner. This data is overlaid onto the resulting CT scan to create a 3D representation of the heart and its electric activity.